Egypt detects 354 new coronavirus cases, 12 deaths on Monday    Egypt condemns Houthi attack on Saudi fuel distribution terminal    Sisi, telecom company Orange discuss increasing cooperation in Egypt    Cairo International Book Fair suspended for five months over coronavirus concerns    Suspension of CAF boss Ahmad opens elections race wide open    GCC countries surpass 1 million COVID-19 cases: Reuters Tally    AstraZeneca novel COVID-19 vaccine can be 90% effective, results show    Egypt's military production minister, S. Korean ambassador discuss boosting industrial cooperation    UN urges civilian protection after Ethiopia's 72-hr deadline for Tigrayan forces    Orascom Development inks $265m loan deal with four banks    International Energy Agency tailors a plan for post COVID-19    Egypt-Kenya bilateral trade hits $303m in H1-20    Suarez says Uruguay players let guard down after spate of COVID-19 cases    Polling stations open at home for 1st stage of Egyptian parliamentary run-offs    Liverpool coach Klopp blasts broadcasters over hectic match schedule    Biden expected to nominate Blinken as secretary of state    Egypt detects 351 new coronavirus cases, 13 deaths on Sunday    Egyptian president inaugurates Middle East and Africa Smart Transportation Fair    Winners of the 5th Sharm El-Sheikh Int'l Theatre Festival for Youth    Egypt confirms 358 new coronavirus cases, 14 deaths on Saturday    BREAKING: Sudan decides not to participate in ministerial meeting on GERD Saturday    G20 to discuss post-pandemic world, back debt relief    First day of Egypt's parliamentary runoffs kicks off for expats    US will reduce number of its troop in Iraq, Afghanistan    Don't miss the concerts of the 12th Cairo International Jazz Festival    Asia forms world's biggest trade bloc, a China-backed group excluding U.S    Egypt unveils largest archaeological discovery in 2020 with over 100 intact sarcophagi    Palestinians mourn the loss their longtime spokesman, Saeb Erekat    Egypt, Ethiopia, Sudan to resume Nile dam talks today    Trump says won't blame Egypt for being ‘upset' over GERD dispute with Ethiopia    1st stage of Egypt's parliamentary elections kicks off on Saturday    Global Finance: Egypt's Tarek Amer among the world's top 20 central bank governors    Legend footballer Lionel Messi says he is forced to stay with Barcelona    Iraqi conglomerate eyes developing land that housed Mubarak-era ruling party HQ    Famous Egyptian actor Mahmoud Yassin passes away at 79    Legend Messi officially wants to leave Barcelona, hands transfer request    The Facebook Preacher's Search for Fame, and Egypt's Economy    Egypt calls on UNSC to address oil spill risks off Yemen coast    Egypt economically strong in face of COVID-19, reforms ongoing: International Cooperation Minister    Arafa Holding reports $144,000 COVID-19-related losses in April    Egypt's efforts in Libya to activate free will of Libyan people: Al-Sisi    Hyksos campaigns were internal takeover, not foreign invaders: study    COVID-19 affects Egypt sporting clubs    COVID-19 will soon turn to seasonal like swine flu: Presidential Health Advisor    ‘Egypt's Support' coalition convenes to discuss its Senate election list    Robbery attempt leads to discovery of Ptolemaic monuments in Qena    Flouting international guidance, Ethiopia unilaterally starts filling its Nile dam    Zaha speaks out after online racial abuse    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.





Germany approves first human trials of new coronavirus vaccine
Published in Amwal Al Ghad on 23 - 04 - 2020

Germany's Federal Institute for Vaccines has approved on Wednesday the first human trials of a potential coronavirus vaccine developed by German biotech company BioNTech.
The trial will see 200 healthy participants between the age of 18 and 55 receive several variants of BioNTech's vaccine as scientists examine its efficacy in providing immunity against the virus.
In a second stage, additional tests will be conducted on more people, including those at higher risk from the coronavirus.
Named BNT162, BioNTech said it was developing this vaccine candidate in cooperation with pharmaceutical giant Pfizer.
BNT162 is also expected to be trialled in the U.S., once regulatory approval for testing on humans had been secured there.
To date, the pandemic has killed more than 177,000 people and infected 2.5 million, according to figures from Johns Hopkins University.
There are 86 teams across the globe currently working to develop a coronavirus vaccine, including a handful at the clinical trial stage.
Germany is second country in Europe, after the UK, approving a human trial.
On Tuesday, British health secretary Matt Hancock announced scientists at Oxford University will start testing a vaccine on people this Thursday.
Around 500 volunteers are expected to take part in the programme by mid-May, with the British government pledging £20 million ($1.26 million) to the Oxford research.
Earlier this month, China approved early-stage human tests for two experimental vaccines, according to state media Xinhua.
These Chinese vaccines are being developed by a Beijing-based unit of Nasdaq-listed Sinovac Biotech and by the Wuhan Institute of Biological Products, a subsidiary of state-run China National Pharmaceutical Group.
In March, authorities in China approved another clinical trial for a vaccine candidate developed by the Academy of Military Medical Sciences and HK-listed biotech company CanSino Bio.
In the United States, drug developer Moderna has started human tests for their vaccine with the U.S. National Institutes of Health.


Clic here to read the story from its source.